Prognostic Value of Serum Neurofilament Light Chain for Disease Activity and Worsening in Patients With Relapsing Multiple Sclerosis: Results From the Phase 3 ASCLEPIOS I and II Trials

OBJECTIVE: This study aims to confirm the prognostic value of baseline serum neurofilament light chain (sNfL) for on-study disease activity and worsening in patients with relapsing MS (RMS). BACKGROUND: Previous post-hoc studies suggested that sNfL could be a prognostic biomarker in RMS. In the phas...

Descripción completa

Detalles Bibliográficos
Autores principales: Ziemssen, Tjalf, Arnold, Douglas L., Alvarez, Enrique, Cross, Anne H., Willi, Roman, Li, Bingbing, Kukkaro, Petra, Kropshofer, Harald, Ramanathan, Krishnan, Merschhemke, Martin, Kieseier, Bernd, Su, Wendy, Häring, Dieter A., Hauser, Stephen L., Kappos, Ludwig, Kuhle, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009385/
https://www.ncbi.nlm.nih.gov/pubmed/35432382
http://dx.doi.org/10.3389/fimmu.2022.852563

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009385/
https://www.ncbi.nlm.nih.gov/pubmed/35432382
http://dx.doi.org/10.3389/fimmu.2022.852563

Ejemplares similares